Joe Y Chang, MD, PhD (Focused Issue: Hypo- and hyper-fractionated radiotherapy in NSCLC using cutting-edge technologies)
UT MD Anderson Cancer Center, Houston, USA
Dr. Joe Y. Chang is currently a tenured Professor, Clinical Section Chief of Thoracic Radiation Oncology and Director of Stereotactic Radiotherapy Program, MD Anderson Cancer Center. He is chair for American College of Radiology (ACR) appropriate criteria Lung cancer expert panel and Chair of Thoracic subcommittee of international Particle Therapy C-Operative Group (PTCOG). He serves as senior associate editor for International Journal of Radiation Oncology Biology Physics (Red Journal) and is an editorial board member for several international medical journals. He is also the president of Sino-American Network of Therapeutic Radiology and Oncology (SANTRO). He was awarded as American Top Physician/Oncologist several times. He is an international known expert in radiotherapy and one of the pioneers in the field of proton therapy and stereotactic radiotherapy in lung cancer. He is PI or Co-PI for many institutional, national and international clinical trials in lung cancer. He has published more than 150 peer-reviewed articles, 20 book chapters related to image-guided radiation therapy, stereotactic ablative radiation therapy, intensity-modulated radiotherapy and proton therapy. He edited book titled “Image-guided radiation therapy in lung cancer” that was published in 2008.
Focused Issue: Hypo- and hyper-fractionated radiotherapy in NSCLC using cutting-edge technologies.